Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-19
DOI
10.3389/fpsyt.2021.704330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Registry-based studies: What they can tell us, and what they cannot
- (2021) Heidi Taipale et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
- (2020) Saurabh S. Kokane et al. BEHAVIOURAL BRAIN RESEARCH
- The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
- (2020) Veronika Andrashko et al. Frontiers in Psychiatry
- Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential
- (2019) Rupert McShane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress
- (2019) Millie Rincón-Cortés et al. BEHAVIOURAL BRAIN RESEARCH
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
- (2017) Elizabeth D. Ballard et al. JOURNAL OF AFFECTIVE DISORDERS
- Clinical Characteristics Associated With Treatment-Resistant Bipolar Disorder
- (2017) Gordon B. Parker et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression
- (2015) Nick Ford et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Pharmacological Approaches for Treatment-resistant Bipolar Disorder
- (2015) Shi Hui Poon et al. Current Neuropharmacology
- Concomitant Benzodiazepine Use Attenuates Ketamine Response
- (2015) Mark A. Frye et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Determinants of Treatment-Resistant Depression
- (2015) Gordon B. Parker et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
- (2015) Níall Lally et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
- (2011) R. Uher et al. PSYCHOLOGICAL MEDICINE
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory
- (2010) Anita J Bechtholt-Gompf et al. NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now